I. Gouin-Thibault

Multimodal assessment of non‐specific hemostatic agents for apixaban reversal

A. Godier, Pascale Gaussem, Anne-Céline Martin, 2015, Journal of thrombosis and haemostasis : JTH.

Comparisons between diluted thrombin time, ecarin chromogenic assays, and UPLC-MS for plasma level dabigatran quantification: Results from DRIVING study.

I. Gouin-Thibault, Virginie Siguret, Ambre de Fautereau-Vassel, 2023, International journal of laboratory hematology.

Predicting the warfarin maintenance dose in elderly inpatients at treatment initiation: accuracy of dosing algorithms incorporating or not VKORC1/CYP2C9 genotypes

M. Loriot, J. Golmard, C. Moreau, 2011, Journal of thrombosis and haemostasis : JTH.

Genetic Factors (VKORC1, CYP2C9, EPHX1, and CYP4F2) Are Predictor Variables for Warfarin Response in Very Elderly, Frail Inpatients

M. Loriot, P. Beaune, J. Golmard, 2010, Clinical pharmacology and therapeutics.

Intravenous thrombolysis for acute ischaemic stroke in patients on direct oral anticoagulants

S. Susen, Y. Gruel, E. Touzé, 2018, European journal of neurology.

Is there a role for the laboratory monitoring in the management of specific antidotes of direct oral anticoagulants?

Georges Jourdi, I. Gouin-Thibault, Virginie Siguret, 2024, Thrombosis research.